Healx

What They Do

AI rare disease drugs.

Ethos

Rare disease patients

Key Facts

Funding: ~$68M · Valuation: Undisclosed · Team: 50-100 · HQ: Cambridge+LDN

Key People

Guilliams (CEO)

← View Healx on the LDN/ai map